Difamilast Patent Expiration

Difamilast was first introduced by Acrotech Biopharma Inc in its drug Adquey on Feb 12, 2026.


Difamilast Patents

Given below is the list of patents protecting Difamilast, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Adquey US10588893 Ointment Containing An Oxazole Compound Dec 31, 2036 Acrotech Biopharma
Adquey USRE46792 Mar 01, 2028 Acrotech Biopharma



Difamilast's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Difamilast Generic API Manufacturers

Given below is the list of companies who have filed for Difamilast generic, along with the locations of their manufacturing plants worldwide.